Literature DB >> 27011206

Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.

Louise K Andersen1, Mark D P Davis.   

Abstract

In Olmsted County, Minn., USA, reliable, population-based epidemiologic research studies can be performed because of a unique medical records linkage system, the Rochester Epidemiology Project (REP). Our objective was to summarize the epidemiologic data describing the prevalence of skin and skin-related diseases derived from the REP and to compare the findings with those from other studies worldwide. Retrospectively, we reviewed the results of population-based REP studies reporting the prevalence of skin and skin-related diseases over more than 4 decades and compared them to other published prevalences globally. Prevalences from the REP reported per 100,000 persons were as follows: hidradenitis suppurativa, 130.0; psoriasis, 700.0; psoriatic arthritis in 1992, 100.0, and in 2000, 160.0; Behçet disease, 5.2; scleroderma, 13.8; dermatomyositis, 21.42; systemic lupus erythematosus (SLE), from 30.5 to 122.0 suspected SLE, 32.8; combined SLE, 41.8; discoid lupus erythematosus, 27.6, and cutaneous lupus erythematosus, 70.4 and 73.2 (from 2 studies). Many of the population-based prevalences of specific skin and skin-related diseases derived from the REP are different from those estimated globally. Suggested reasons for disparity in the prevalences globally may include differences in the type of reported prevalence, study methodology, geographic areas, ethnic groups, age distribution, and socioeconomic status.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27011206      PMCID: PMC5061335          DOI: 10.1159/000444580

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  42 in total

1.  Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.

Authors:  Emily C Somers; Wendy Marder; Patricia Cagnoli; Emily E Lewis; Peter DeGuire; Caroline Gordon; Charles G Helmick; Lu Wang; Jeffrey J Wing; J Patricia Dhar; James Leisen; Diane Shaltis; W Joseph McCune
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

2.  Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan.

Authors:  Kuang-Hui Yu; Lai-Chu See; Chang-Fu Kuo; I-Jun Chou; Meng-Jiun Chou
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

3.  The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991.

Authors:  M Shbeeb; K M Uramoto; L E Gibson; W M O'Fallon; S E Gabriel
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

4.  Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation.

Authors:  P J Roberts-Thomson; J G Walker; T Y-T Lu; A Esterman; P Hakendorf; M D Smith; M J Ahern
Journal:  Intern Med J       Date:  2006-08       Impact factor: 2.048

5.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

6.  Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires.

Authors:  Javier Rosa; Leandro Ferreyra Garrot; David Alejandro Navarta; Carla Saucedo; Marina Scolnik; Zaida Bedran; Maria Victoria Garcia; Mirtha Sabelli; Luis Jose Catoggio; Enrique Roberto Soriano
Journal:  J Clin Rheumatol       Date:  2013-09       Impact factor: 3.517

7.  Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001.

Authors:  Yannis Alamanos; Nikolaos G Papadopoulos; Paraskevi V Voulgari; Christos Siozos; Dimitrios N Psychos; Maria Tympanidou; Alexandros A Drosos
Journal:  J Rheumatol       Date:  2003-12       Impact factor: 4.666

8.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

Authors:  K M Uramoto; C J Michet; J Thumboo; J Sunku; W M O'Fallon; S E Gabriel
Journal:  Arthritis Rheum       Date:  1999-01

9.  The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.

Authors:  Roderick J Hay; Nicole E Johns; Hywel C Williams; Ian W Bolliger; Robert P Dellavalle; David J Margolis; Robin Marks; Luigi Naldi; Martin A Weinstock; Sarah K Wulf; Catherine Michaud; Christopher J L Murray; Mohsen Naghavi
Journal:  J Invest Dermatol       Date:  2013-10-28       Impact factor: 8.551

10.  Scleroderma prevalence: demographic variations in a population-based sample.

Authors:  S Bernatsky; L Joseph; C A Pineau; P Belisle; M Hudson; A E Clarke
Journal:  Arthritis Rheum       Date:  2009-03-15
View more
  6 in total

Review 1.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

Review 2.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 3.  Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.

Authors:  Jasmine N Stannard; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 4.  TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling.

Authors:  Rambon Shamilov; Brian J Aneskievich
Journal:  J Immunol Res       Date:  2018-10-03       Impact factor: 4.818

5.  Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.

Authors:  Natalia Kirsten; Nicole Zander; Matthias Augustin
Journal:  Arch Dermatol Res       Date:  2020-04-22       Impact factor: 3.017

6.  Fractional Photothermolysis for Treatment of a Residual Discoid Lupus Erythematosus Lesion: A Case Report.

Authors:  David Alvarez Martinez; Emmanuel Laffitte; Garuna Kositratna; Hans-Joachim Laubach
Journal:  Ann Dermatol       Date:  2022-08       Impact factor: 0.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.